| Cited nodes | Nodes / Authors | GCS | LCS |
| 1 | 1 2000 SCIENCE 290(5491):463-+
Shen XF; Siliciano RF
AIDS - Preventing AIDS but not HIV-1 infection with a DNA vaccine | 2 | 0
|
| 0 | 2 2000 SCIENCE 290(5491):486-492
Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan LM; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination | 120 | 120
|
| 3 | 3 2001 AIDS 15():S117-S126
Allen TM; Watkins DI
New insights into evaluating effective T-cell responses to HIV | 1 | 0
|
| 5 | 4 2001 AIDS 15():S147-S158
Schultz AM; Bradac JA
The HIV vaccine pipeline, from preclinical to phase III | 1 | 0
|
| 1 | 5 2001 AIDS RESEARCH AND HUMAN RETROVIRUSES 17(9):829-835
Ross TM; Xu Y; Green TD; Montefiori DC; Robinson HL
Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins | 1 | 0
|
| 1 | 6 2001 ANNALS OF INTERNAL MEDICINE 134(10):978-996
Hogan CM; Hammer SM
Host determinants in HIV infection and disease - Part 2: Genetic factors and implications for antiretroviral therapeutics | 2 | 0
|
| 1 | 7 2001 BRITISH MEDICAL BULLETIN 58():205-218
Hanke T
Prospect of a prophylactic vaccine for HIV | 1 | 0
|
| 1 | 8 2001 CANCER RESEARCH 61(24):8782-8786
Meng WS; Butterfield LH; Ribas A; Dissette VB; Heller JB; Miranda GA; Glaspy JA; McBride WH; Economou JS
alpha-fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination | 1 | 0
|
| 2 | 9 2001 CELL 106(5):539-549
Rose NF; Marx PA; Luckay A; Nixon DF; Moretto WJ; Donahoe SM; Montefiori D; Roberts A; Buonocore L; Rose JK
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants | 9 | 5
|
| 2 | 10 2001 CLINICAL IMMUNOLOGY 101(2):152-157
Anderson DE; Carlos MP; Nguyen L; Torres JV
Overcoming original (antigenic) sin | 0 | 0
|
| 1 | 11 2001 CLINICAL INFECTIOUS DISEASES 32(12):1738-1755
Sereti I; Lane HC
Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies | 1 | 0
|
| 3 | 12 2001 CURRENT OPINION IN IMMUNOLOGY 13(4):479-482
Barouch DH; Letvin NL
CD8(+) cytotoxic T lymphocyte responses to lentiviruses and herpesviruses | 1 | 0
|
| 2 | 13 2001 CURRENT OPINION IN IMMUNOLOGY 13(4):489-495
Mascola JR; Nabel GJ
Vaccines for the prevention of HIV-1 disease | 3 | 1
|
| 1 | 14 2001 CURRENT OPINION IN INFECTIOUS DISEASES 14(4):467-480
Lee LM; Henderson DK
Emerging viral infections | 0 | 0
|
| 3 | 15 2001 CURRENT OPINION IN MOLECULAR THERAPEUTICS 3(4):375-384
Clark KR; Johnson PR
Gene delivery of vaccines for infectious disease | 0 | 0
|
| 1 | 16 2001 CURRENT PHARMACEUTICAL DESIGN 7(11):993-1013
Alfano M; Poli G
Cytokine and chemokine based control of HIV infection and replication | 3 | 0
|
| 1 | 17 2001 CYTOKINE 14(2):63-77
Gaffen SL
Signaling domains of the interleukin 2 receptor | 0 | 0
|
| 1 | 18 2001 EUROPEAN JOURNAL OF IMMUNOLOGY 31(12):3557-3566
Belyakov IM; Wang J; Koka R; Ahlers JD; Snyder JT; Tse R; Cox J; Gibbs JS; Margulies DH; Berzofsky JA
Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion | 0 | 0
|
| 1 | 19 2001 EUROPEAN JOURNAL OF IMMUNOLOGY 31(12):3782-3788
Oxenius A; Fidler S; Brady M; Dawson SJ; Ruth K; Easterbrook PJ; Weber JN; Phillips RE; Price DA
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection | 1 | 1
|
| 3 | 20 2001 FEMS MICROBIOLOGY LETTERS 200(2):123-129
Schnell MJ
Viral vectors as potential HIV-1 vaccines | 0 | 0
|
| 1 | 21 2001 HUMAN GENE THERAPY 12(9):1047-1061
Xin KQ; Urabe M; Yang J; Nomiyama K; Mizukami H; Hamajima K; Nomiyama H; Saito T; Imai M; Monahan J; Okuda K; Ozawa K; Okuda K
A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus | 3 | 2
|
| 2 | 22 2001 IMMUNOLOGIC RESEARCH 24(3):225-244
McKenzie BS; Corbett AJ; Brady JL; Dyer CM; Strugnell RA; Kent SJ; Kramer DR; Boyle JS; Lew AM
Nucleic acid vaccines - Tasks and tactics | 0 | 0
|
| 1 | 23 2001 IMMUNOLOGICAL REVIEWS 183():5-9
Bontrop RE
Non-human primates: essential partners in biomedical research | 0 | 0
|
| 3 | 24 2001 IMMUNOLOGICAL REVIEWS 183():94-108
Kent SJ; Ada GL; Hayes E; Lewis IM
Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques | 0 | 0
|
| 1 | 25 2001 IMMUNOLOGY LETTERS 79(1-2):57-61
Barouch DH; Fu TM; Montefiori DC; Lewis MG; Shiver JW; Letvin NL
Vaccine-elicited immune responses prevent clinical AIDS in SHIV89.6P-infected rhesus monkeys | 1 | 0
|
| 1 | 26 2001 IMMUNOLOGY LETTERS 79(1-2):77-84
O'Connor D; Allen T; Watkins DI
Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development? | 1 | 0
|
| 1 | 27 2001 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 285(5):606-611
Letvin NL; Bloom BR; Hoffman SL
Prospects for vaccines to protect against AIDS, tuberculosis, and malaria | 4 | 1
|
| 1 | 28 2001 JOURNAL OF CLINICAL INVESTIGATION 107(3):273-275
Letvin NL; Walker BD
HIV versus the immune system: another apparent victory for the virus | 1 | 0
|
| 1 | 29 2001 JOURNAL OF IMMUNOLOGY 167(9):4996-5003
Charini WA; Kuroda MJ; Schmitz JE; Beaudry KR; Lin WY; Lifton MA; Krivulka GR; Necker A; Letvin NL
Clonally diverse CTL response to a dominant viral epitope recognizes potential epitope variants | 0 | 0
|
| 1 | 30 2001 JOURNAL OF VIROLOGY 75(5):2462-2467
Barouch DH; Craiu A; Santra S; Egan MA; Schmitz JE; Kuroda MJ; Fu TM; Nam JH; Wyatt LS; Lifton MA; Krivulka GR; Nickerson CE; Lord CI; Moss B; Lewis MG; Hirsch VM; Shiver JW; Letvin NL
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys | 10 | 7
|
| 1 | 31 2001 JOURNAL OF VIROLOGY 75(9):4430-4434
McGettigan JP; Foley HD; Belyakov IM; Berzofsky JA; Pomerantz RJ; Schnell MJ
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross- reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates | 6 | 3
|
| 1 | 32 2001 JOURNAL OF VIROLOGY 75(11):5151-5158
Barouch DH; Santra S; Kuroda MJ; Schmitz JE; Plishka R; Buckler-White A; Gaitan AE; Zin R; Nam JH; Wyatt LS; Lifton MA; Nickerson CE; Moss B; Montefiori DC; Hirsch VM; Letvin NL
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination | 14 | 10
|
| 1 | 33 2001 JOURNAL OF VIROLOGY 75(12):5646-5655
Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus | 8 | 0
|
| 1 | 34 2001 JOURNAL OF VIROLOGY 75(13):5879-5890
Montefiori DC; Safrit JT; Lydy SL; Barry AP; Bilska M; Vo HTT; Klein M; Tartaglia J; Robinson HL; Rovinski B
Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques | 2 | 1
|
| 1 | 35 2001 JOURNAL OF VIROLOGY 75(15):6953-6961
Forthal DN; Landucci G; Daar ES
Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 the presence of natural-killer effector cells | 2 | 0
|
| 1 | 36 2001 JOURNAL OF VIROLOGY 75(16):7435-7452
Crotty S; Miller CJ; Lohman BL; Neagu MR; Compton L; Lu D; Lu FXS; Fritts L; Lifson JD; Andino R
Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors | 4 | 3
|
| 1 | 37 2001 JOURNAL OF VIROLOGY 75(16):7470-7480
Hofmann-Lehmann R; Vlasak J; Rasmussen RA; Smith BA; Baba TW; Liska V; Ferrantelli F; Montefiori DC; McClure HM; Anderson DC; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Katinger H; Stiegler G; Cavacini LA; Posner MR; Chou TC; Andersen J; Ruprecht RM
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge | 5 | 0
|
| 1 | 38 2001 JOURNAL OF VIROLOGY 75(17):8340-8347
Parren PWHI; Marx PA; Hessell AJ; Luckay A; Harouse J; Cheng-Mayer C; Moore JP; Burton DR
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro | 9 | 2
|
| 1 | 39 2001 JOURNAL OF VIROLOGY 75(18):8681-8689
Kaslow RA; Rivers C; Tang JM; Bender TJ; Goepfert PA; El Habib R; Weinhold K; Mulligan MJ
Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines | 3 | 1
|
| 2 | 40 2001 JOURNAL OF VIROLOGY 75(18):8724-8732
McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus- based vaccine vector | 5 | 0
|
| 1 | 41 2001 JOURNAL OF VIROLOGY 75(19):9210-9228
Novitsky V; Rybak N; McLane MF; Gilbert P; Chigwedere P; Klein I; Gaolekwe S; Chang SY; Peter T; Thior I; Ndung'U T; Vannberg F; Foley BT; Marlink R; Lee TH; Essex M
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific Elispot-based cytotoxic T- lymphocyte responses for AIDS vaccine design | 3 | 0
|
| 1 | 42 2001 JOURNAL OF VIROLOGY 75(19):9287-9296
Malenbaum SE; Yang D; Cheng-Mayer C
Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp120 in humans and macaques | 0 | 0
|
| 1 | 43 2001 JOURNAL OF VIROLOGY 75(20):9665-9670
Shata MT; Hone DM
Vaccination with a Shigella DNA vaccine vector induces antigen- specific CD8(+) T cells and antiviral protective immunity | 0 | 0
|
| 2 | 44 2001 JOURNAL OF VIROLOGY 75(20):9771-9779
Norris PJ; Sumaroka M; Brander C; Moffett HF; Boswell SL; Nguyen T; Sykulev Y; Walker BD; Rosenberg ES
Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones | 1 | 0
|
| 1 | 45 2001 JOURNAL OF VIROLOGY 75(21):10179-10186
Robinson S; Charini WA; Newberg MH; Kuroda MJ; Lord CI; Letvin NL
A commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02 | 1 | 0
|
| 5 | 46 2001 JOURNAL OF VIROLOGY 75(22):10906-10911
Parker CE; Deterding LJ; Hager-Braun C; Binley JM; Schulke N; Katinger H; Moore JP; Tomer KB
Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5 | 3 | 0
|
| 2 | 47 2001 JOURNAL OF VIROLOGY 75(22):11234-11238
Parker RA; Regan MM; Reimann KA
Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: Implications for using nonhuman primate AIDS models to test vaccines and therapeutics | 1 | 1
|
| 2 | 48 2001 JOURNAL OF VIROLOGY 75(23):11891-11896
Matano T; Kano M; Nakamura H; Takeda A; Nagai Y
Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen | 2 | 1
|
| 2 | 49 2001 JOURNAL OF VIROLOGY 75(24):11983-11991
Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection | 4 | 1
|
| 2 | 50 2001 LANCET 357(9270):1799-1799
Markus MB; Fincham JE
Helminthiasis and HIV vaccine efficacy | 2 | 0
|
| 1 | 51 2001 NATURE 410(6831):995-1001
Richman DD
HIV chemotherapy | 15 | 1
|
| 1 | 52 2001 NATURE 410(6831):1002-1007
Nabel GJ
Challenges and opportunities for development of an AIDS vaccine | 17 | 6
|
| 1 | 53 2001 NATURE 412(6844):334-338
Goulder PJR; Brander C; Tang YH; Tremblay C; Colbert RA; Addo MM; Rosenberg ES; Nguyen T; Allen R; Trocha A; Altfeld M; He SQ; Bunce M; Funkhouser R; Pelton SI; Burchett SK; McIntosh K; Korber BTM; Walker BD
Evolution and transmission of stable CTL escape mutations in HIV infection | 12 | 2
|
| 2 | 54 2001 NATURE MEDICINE 7(8):881-884
Altfeld M; Walker BD
Less is more? STI in acute and chronic HIV-1 infection | 8 | 1
|
| 2 | 55 2001 NATURE MEDICINE 7(11):1225-1231
Chen XN; Scala G; Quinto I; Liu WM; Chun TW; Justement JS; Cohen OJ; vanCott TC; Iwanicki M; Lewis MG; Greenhouse J; Barry T; Venzon D; Fauci AS
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV- 1 epitopes | 2 | 1
|
| 2 | 56 2001 NATURE MEDICINE 7(12):1320-1326
Belyakov IM; Hel Z; Kelsall B; Kuznetsov VA; Ahlers JD; Nacsa J; Watkins DI; Allen TM; Sette A; Altman J; Woodward R; Markham PD; Clements JD; Franchini G; Strober W; Berzofsky JA
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques | 2 | 1
|
| 3 | 57 2001 NEW ENGLAND JOURNAL OF MEDICINE 345(14):1042-1053
Ada G
Advances in immunology - Vaccines and vaccination | 6 | 0
|
| 1 | 58 2001 PROTEIN EXPRESSION AND PURIFICATION 23(2):270-281
Grimm KM; Trigona WL; Heidecker GJ; Joyce JG; Fu TM; Shiver JW; Keller PM; Cook JC
An enhanced and scalable process for the purification of SIV gag-specific MHC tetramer | 0 | 0
|
| 1 | 59 2001 SCIENCE 291(5501):46-46
Markus MB; Fincham JE
Helminthic infection and HIV vaccine trials | 3 | 1
|
| 1 | 60 2001 SCIENCE 292(5514):69-74
Amara RR; Villinger F; Altman JD; Lydy SL; O'Neil SP; Staprans SI; Montefiori DC; Xu Y; Herndon JG; Wyatt LS; Candido MA; Kozyr NL; Earl PL; Smith JM; Ma HL; Grimm BD; Hulsey ML; Miller J; McClure HM; McNicholl JM; Moss B; Robinson HL
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine | 71 | 47
|
| 1 | 61 2001 VACCINE 19(15-16):2012-2019
Vassilev VB; Gil LHVG; Donis RO
Microparticle-mediated RNA immunization against bovine viral diarrhea virus | 3 | 0
|
| 2 | 62 2001 VACCINE 19(32):4865-4873
Loomis-Huff JE; Eberle R; Lockridge KM; Rhodes G; Barry PA
Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques | 1 | 0
|
| 2 | 63 2001 VACCINE 20(1-2):3-6
Altes HK; Price DA; Jansen VAA
Effector cytotoxic T lymphocyte numbers induced by vaccination should exceed levels in chronic infection for protection from HIV | 1 | 1
|
| 3 | 64 2001 VACCINE 20(3-4):304-321
Mooij P; Heeney JL
Rational development of prophylactic HIV vaccines based on structural and regulatory proteins | 0 | 0
|
| 1 | 65 2001 VACCINE 20(5-6):688-705
Peters BS
The basis for HIV immunotherapeutic vaccines | 0 | 0
|
| 2 | 66 2001 VACCINE 20(5-6):744-755
Shankar P; Schlom J; Hodge JW
Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3) | 0 | 0
|
| 2 | 67 2001 VACCINE 20(5-6):797-804
Chujoh Y; Matsuo K; Yoshizaki H; Nakasatomi T; Someya K; Okamoto Y; Naganawa S; Haga S; Yoshikura H; Yamazaki A; Yamazaki S; Honda M
Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B ' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine | 0 | 0
|
| 1 | 68 2001 VIROLOGY 285(1):1-5
Kumar A; Narayan O
Immunization for long-term protection against AIDS using the macaque model | 0 | 0
|
| 1 | 69 2001 VIROLOGY 285(2):204-217
Kim JJ; Yang JS; Nottingham LK; Lee DJ; Lee M; Manson KH; Wyand MS; Boyer JD; Ugen KE; Weiner DB
Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization | 1 | 0
|
| 1 | 70 2001 VIROLOGY 287(1):71-78
Kent SJ; Cameron PU; Reece JC; Thompson PR; Purcell DFJ
Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo | 2 | 0
|
| 1 | 71 2001 VIROLOGY 291(2):272-284
Fang ZY; Limbach K; Tartaglia J; Hammonds J; Chen XM; Spearman P
Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells | 0 | 0
|
| 1 | 72 2002 AIDS RESEARCH AND HUMAN RETROVIRUSES 18(4):289-293
Xu JQ; Whitman L; Lori F; Lisziewicz J
Methods of using interleukin 2 to enhance HIV-specific immune responses | 0 | 0
|
| 3 | 73 2002 ANNUAL REVIEW OF IMMUNOLOGY 20():73-99
Letvin NL; Barouch DH; Montefiori DC
Prospects for vaccine protection against HIV-1 infection and AIDS | 0 | 0
|
| 2 | 74 2002 ANNUAL REVIEW OF MEDICINE 53():149-172
Gandhi RT; Walker BD
Immunologic control of HIV-1 | 1 | 0
|
| 1 | 75 2002 CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 9(3):525-529
Schmitz JL; Denny TN; Garcia A; Lathey JL
Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays | 0 | 0
|
| 1 | 76 2002 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 127(3):402-411
Imami N; Gotch F
Prospects for immune reconstitution in HIV-1 infection | 0 | 0
|
| 1 | 77 2002 COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES 25(3):149-158
Miyamoto T; Min WG; Lillehoj HS
Kinetics of interleukin-2 production in chickens infected with Eimeria tenella | 0 | 0
|
| 1 | 78 2002 HYBRIDOMA AND HYBRIDOMICS 21(2):129-134
Dietzschold B; Schnell MJ
New approaches to the development of live attenuated rabies vaccines | 0 | 0
|
| 2 | 79 2002 IMMUNOLOGIC RESEARCH 25(1):53-74
Edgeworth RL; Juan HS; Rosenzweig JA; Nguyen NL; Boyer JD; Ugen KE
Vaccine development against HIV-1 - Current perspectives and future directions | 0 | 0
|
| 1 | 80 2002 INTERNATIONAL JOURNAL FOR PARASITOLOGY 32(5):543-550
Boyer JD; Nath B; Schumann K; Curley E; Manson K; Kim J; Weiner DB
IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaques | 0 | 0
|
| 1 | 81 2002 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 29(3):254-261
Gupta K; Hudgens M; Corey L; McElrath MJ; Weinhold K; Montefiori DC; Gorse GJ; Frey SE; Keefer MC; Evans TG; Dolin R; Schwartz DH; Harro C; Graham B; Spearman PW; Mulligan M; Goepfert P
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1- uninfected adults: AIDS vaccine evaluation group protocol 022A | 0 | 0
|
| 8 | 82 2002 JOURNAL OF BIOMEDICAL SCIENCE 9(2):100-111
Smith SM
HIV vaccine development in the nonhuman primate model of AIDS | 0 | 0
|
| 2 | 83 2002 JOURNAL OF GENERAL VIROLOGY 83():75-80
Wee EGT; Patel S; McMichael AJ; Hanke T
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques | 2 | 1
|
| 1 | 84 2002 JOURNAL OF GENERAL VIROLOGY 83():81-91
Vogel TU; Beer BE; zur Megede J; Ihlenfeldt HG; Jung G; Holzammer S; Watkins DI; Altman JD; Kurth R; Norley S
Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell- associated but not plasma virus load following challenge | 0 | 0
|
| 2 | 85 2002 JOURNAL OF GENERAL VIROLOGY 83():369-381
Brinster C; Chen M; Boucreux D; Paranhos-Baccala G; Liljestrom P; Lemmonier F; Inchauspe G
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles | 0 | 0
|
| 1 | 86 2002 JOURNAL OF IMMUNOLOGY 168(1):332-337
McKay PF; Schmitz JE; Barouch DH; Kuroda MJ; Lifton MA; Nickerson CE; Gorgone DA; Letvin NL
Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys | 0 | 0
|
| 1 | 87 2002 JOURNAL OF IMMUNOLOGY 168(1):379-391
Singh RAK; Wu L; Barry MA
Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine | 0 | 0
|
| 3 | 88 2002 JOURNAL OF IMMUNOLOGY 168(2):562-568
Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
Potent CD4(+) T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF | 0 | 0
|
| 5 | 89 2002 JOURNAL OF IMMUNOLOGY 168(4):1847-1853
Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL
Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys | 1 | 1
|
| 3 | 90 2002 JOURNAL OF IMMUNOLOGY 168(8):4001-4011
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
Detailed analysis of CD4(+) Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope | 0 | 0
|
| 1 | 91 2002 JOURNAL OF IMMUNOLOGY 168(10):4998-5004
Wolkers MC; Toebes M; Okabe M; Haanen JBAG; Schumacher TNM
Optimizing the efficacy of epitope-directed DNA vaccination | 0 | 0
|
| 1 | 92 2002 JOURNAL OF INFECTIOUS DISEASES 185(3):306-314
Saavedra-Lozano J; McCoig C; Xu JB; Cao YY; Keiser P; Ghetie V; Siliciano RF; Siliciano JD; Picker LJ; Ramilo O; Vitetta ES
An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV- positive persons | 0 | 0
|
| 1 | 93 2002 JOURNAL OF LEUKOCYTE BIOLOGY 71(4):565-581
Brassard DL; Grace MJ; Bordens RW
Interferon-alpha as an immunotherapeutic protein | 0 | 0
|
| 3 | 94 2002 JOURNAL OF MEDICAL PRIMATOLOGY 31(1):40-60
Rasmussen RA; Hofmann-Lehmann R; Montefiori DC; Li PL; Liska V; Vlasak J; Baba TW; Schmitz JE; Kuroda MJ; Robinson HL; McClure HM; Lu S; Hu SL; Rizvi TA; Ruprecht RM
DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus | 0 | 0
|
| 2 | 95 2002 JOURNAL OF THEORETICAL BIOLOGY 214(4):633-646
Altes HK; Wodarz D; Jansen VAA
The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination | 0 | 0
|
| 1 | 96 2002 JOURNAL OF VIROLOGY 76(1):185-194
Casimiro DR; Tang AM; Perry HC; Long RS; Chen MC; Heidecker GJ; Davies ME; Freed DC; Persaud NV; Dubey S; Smith JG; Havlir D; Richman D; Chastain MA; Simon AJ; Fu TM; Emini EA; Shiver JW
Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene | 0 | 0
|
| 1 | 97 2002 JOURNAL OF VIROLOGY 76(1):292-302
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency | 3 | 1
|
| 2 | 98 2002 JOURNAL OF VIROLOGY 76(1):379-391
Igarashi T; Brown CR; Byrum RA; Nishimura Y; Endo Y; Plishka RJ; Buckler C; Buckler-White A; Miller G; Hirsch VM; Martin MA
Rapid and irreversible CD4(+) T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIVDH12R is systemic and synchronous | 0 | 0
|
| 2 | 99 2002 JOURNAL OF VIROLOGY 76(2):688-696
Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
The simian immunodeficiency virus Delta nef vaccine, after application to the tonsils of rhesus macaques, replicates primarily within CD4+T cells and elicits a local perforin- positive CD8+T-Cell response | 0 | 0
|
| 2 | 100 2002 JOURNAL OF VIROLOGY 76(2):875-884
Mothe BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection | 0 | 0
|
| 5 | 101 2002 JOURNAL OF VIROLOGY 76(5):2298-2305
Edwards BH; Bansal A; Sabbaj S; Bakari J; Mulligan MJ; Goepfert PA
Magnitude of functional CD8(+) T-cell responses to the Gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma | 0 | 0
|
| 4 | 102 2002 JOURNAL OF VIROLOGY 76(7):3309-3317
Fuller DH; Rajakumar PA; Wilson LA; Trichel AM; Fuller JT; Shipley T; Wu MS; Weis K; Rinaldo CR; Haynes JR; Murphey-Corb M
Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine | 0 | 0
|
| 1 | 103 2002 JOURNAL OF VIROLOGY 76(11):5565-5580
Hocknell PK; Wiley RD; Wang XQ; Evans TG; Bowers WJ; Hanke T; Federoff HJ; Dewhurst S
Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses | 0 | 0
|
| 5 | 104 2002 JOURNAL OF VIROLOGY 76(12):6138-6146
Amara RR; Smith JM; Staprans SI; Montefiori DC; Villinger F; Altman JD; O'Neil SP; Kozyr NL; Xu Y; Wyatt LS; Earl PL; Herndon JG; McNicholl JM; McClure HM; Moss B; Robinson HL
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine | 0 | 0
|
| 5 | 105 2002 JOURNAL OF VIROLOGY 76(12):6376-6381
Santra S; Barouch DH; Kuroda MJ; Schmitz JE; Krivulka GR; Beaudry K; Lord CI; Lifton MA; Wyatt LS; Moss B; Hirsch VM; Letvin NL
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection | 0 | 0
|
| 5 | 106 2002 LANCET INFECTIOUS DISEASES 2(6):353-367
Vandepapeliere P
Therapeutic vaccination against chronic viral infections | 0 | 0
|
| 1 | 107 2002 MOLECULAR THERAPY 5(1):33-41
Strayer DS; Branco F; Landre J; BouHamdan M; Shaheen F; Pomerantz RJ
Combination genetic therapy to inhibit HIV-1 | 0 | 0
|
| 2 | 108 2002 NATURE 415(6869):331-335
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang LY; Harris VA; Long RS; Liang XP; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen MC; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity | 5 | 4
|
| 5 | 109 2002 NATURE 415(6869):335-339
Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes | 6 | 3
|
| 1 | 110 2002 NATURE 415(6872):694-701
Richie TL; Saul A
Progress and challenges for malaria vaccines | 0 | 0
|
| 11 | 111 2002 NATURE MEDICINE 8(3):207-210
Feinberg MB; Moore JP
AIDS vaccine models: Challenging challenge viruses | 1 | 0
|
| 1 | 112 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(1):4-6
Havlir DV
Structured intermittent treatment for HIV disease: Necessary concession or premature compromise? | 0 | 0
|
| 2 | 113 2002 VACCINE 20(9-10):1295-1307
Wierzbicki A; Kiszka I; Kaneko H; Kmieciak D; Wasik TJ; Gzyl J; Kaneko Y; Kozbor D
Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein | 0 | 0
|
| 3 | 114 2002 VACCINE 20(15):1918-1921
McMichael A; Mwau M; Hanke T
HIV T cell vaccines, the importance of clades | 0 | 0
|
| 2 | 115 2002 VACCINE 20(15):1949-1955
Amara RR; Villinger F; Altman JD; Lydy SL; O'Neil SP; Staprans SI; Montefiori DC; Xu Y; Herndon JG; Wyatt LS; Candido MA; Kozyr NL; Earl PL; Smith JM; Ma HL; Grimm BD; Hulsey ML; McClure HM; McNicholl JM; Moss B; Robinson HL
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine | 0 | 0
|
| 1 | 116 2002 VACCINE 20(15):1961-1963
Heeney JL
The critical role of CD4(+) T-cell help in immunity to HIV | 0 | 0
|
| 2 | 117 2002 VACCINE 20(15):1985-1987
Johnson RP
Mechanisms of protection against simian immunodeficiency virus infection | 0 | 0
|
| 2 | 118 2002 VACCINE 20(15):1995-1998
Hanke T; McMichael AJ; Mwau M; Wee EGT; Ceberej I; Patel S; Sutton J; Tomlinson M; Samuel RV
Development of a DNA-MVA/HIVA vaccine for Kenya | 0 | 0
|
| 3 | 119 2002 VACCINE 20(17-18):2382-2395
Sykes KF; Lewis MG; Squires B; Johnston SA
Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge | 0 | 0
|
| 3 | 120 2002 VIROLOGY 294(2):270-281
Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric env protein boost in the SHIV rhesus macaque model | 0 | 0
|
| 2 | 121 2002 VIROLOGY 295(1):133-146
Mackay GA; Niu YF; Liu ZC; Mukherjee S; Li Z; Adany I; Buch S; Zhuge W; McClure HM; Narayan O; Smith MS
Presence of intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques | 0 | 0
|